Molecular profiling in patients with advanced lung or thymic cancer previously treated with immune checkpoint inhibitor therapy.

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Molecular profiling in patients with advanced lung or thymic cancer previously treated with immune checkpoint inhibitor therapy.

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.